安科生物(300009.SZ):董事、高管短線交易及致歉
格隆匯11月16日丨安科生物(300009.SZ)公佈,公司董事、高級管理人員王榮海在減持公司股票過程中出現短線交易的行為。
根據公司於2021年4月23日披露的《關於公司部分董事、監事、高級管理人員減持股份預披露公吿》,王榮海於2021年11月15日以競價交易方式減持公司股票1萬股,成交均價為12.69元/股。 而在2021年6月3日,其配偶肖俊霞因誤操作,通過二級市場集中競價方式買入公司股票100股,買入價格為16.78元/股。
上述交易行為違反了《證券法》、《深圳證券交易所創業板上市公司規範運作指引》等有關規定,構成短線交易行為。
公司在獲悉上述短線交易行為後,高度重視,及時核查相關情況。經核查,由於其配偶上述買入行為屬於誤操作,王榮海在本次減持時未想起其配偶的買入行為,從而形成了本次短線交易。該筆短線交易行為不存在因獲悉內幕信息而交易公司股票的情形,亦不存在利用短線交易謀求利益的目的。
此次短線交易發生後,公司董事會已對王榮海進行了嚴厲的批評教育。王榮海本次操作不具有短線交易的主觀故意,且已深刻認識到嚴重性,對本次操作構成的短線交易給公司和市場帶來的不良影響,深表自責,向廣大投資者致以誠摯的歉意,並表示將認真學習並自覺遵守相關法律法規,規範本人及近親屬買賣公司股票的行為。
本次短線交易行為產生收益為-409元,計算方法:(賣出均價—買入均價)*買入數量。鑑於本次交易未產生收益,故不存在將收益交至公司的情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.